Abstract | Gram-negative bacteria decorate their outermost surface structure, lipopolysaccharide, with elaborate chemical moieties, which effectively disguises them from immune surveillance and protects them from the onslaught of host defences. Many of these changes occur on the lipid A moiety of lipopolysaccharide, a component that is crucial for host recognition of Gram-negative infection. In this Review, we describe the regulatory mechanisms controlling lipid A modification and discuss the impact of modifications on pathogenesis, bacterial physiology and bacterial interactions with the host immune system.
The bacterial cell envelope is a complex structure that protects the cell from the surrounding environment. A defining feature of Gram-negative bacteria is the presence of an outer membrane, which is an asymmetrical bilayer with glycerophospholipids confined to the inner leaflet and lipopolysaccharide (LPS) anchored to the outer leaflet 1 (FIG. 1a,b) . Similarly to most cell envelope components, LPS is made at the cytoplasmic face of the inner membrane and must be transported across the two bilayers and the periplasm to become integrated in the outer membrane 1 . LPS is composed of three domains: the lipid A hydrophobic anchor, the core oligosaccharide and the O antigen 1 (FIG. 1b) . Some organisms (for example, Neisseria spp.) produce lipooligosaccharide (LOS), in which the repeating O antigen domain is absent and is replaced by an extended core region 2 . Lipid A, the endotoxic portion of LPS and the site for many LPS modifications, is initially synthesized as a β-1′,6-linked disaccharide of glucosamine that is both phosphorylated and fatty acylated (FIG. 1c) . In some organisms, such as Escherichia coli K12, this structure represents the typical form of lipid A in the outer membrane. Despite initial studies reporting that lipid A could be modified with polar substituents (such as amino sugars 3 ), it was nevertheless viewed as a static structure. This view changed in the late 1990s following the characterization of the lipid A biosynthesis pathway, which established a foundation for studies which discovered that lipid A is altered after synthesis [4] [5] [6] . In fact, Gram-negative organisms have evolved several LPS modification strategies that allow these organisms to adapt to their unpredictable and often hostile surroundings 7 . During and after trafficking to the cell surface, lipid A can undergo extensive remodelling, resulting in the wide variety of lipid A structures that are observed across species (FIG. 1d) . This is accomplished by diverse lipid A modification enzymes that remove or add acyl chains and phosphate groups, as well as other enzymes that transfer various constituents onto the molecule, such as sugars, phosphoryl containing groups and even an amino acid, all of which can influence bacterial inter actions with the host. The term lipid A modification is used throughout this Review to refer to biological modification of lipid A in the bacterial cell as well as artificial modification in vitro. Modifications also occur on other moieties of LPS
, but these non-lipid A modifications are not the focus of this Review.
Lipid A alterations directly affect pathogenesis by changing outer-membrane permeability, promoting resistance to antimicrobial peptides and interfering with the ability of the host to recognize LPS as a conserved microorganism-associated molecular pattern (MAMP) 7 . The diversity of LPS modification systems is quite extraordinary, and the accumulated knowledge about these systems has provided deeper insight into bacterial mechanisms that contribute to human disease and immunity. In this Review, we describe the mechanisms that regulate lipid A remodelling, the host defence systems that recognize this molecule and the strategies that bacteria have evolved to use lipid A modifications for their own benefit. Finally, we discuss the interplay between lipid A modification systems and bacterial physiology. 123 . b | Schematic of the Gram-negative cell envelope, showing the typical inner and outer bilayers that are separated by the periplasm, which contains peptidoglycan (PG). The outer leaflet of the outer membrane contains lipopolysaccharide (LPS), which is anchored to the membrane by the LPS lipid A domain 1 . The inner leaflet of the outer membrane and also the entire inner membrane are composed of phospholipids only, and both bilayers can contain a range of different types of membrane protein. c | The lipid A and inner core (Kdo (3-deoxy-d-manno-octulosonic acid)) portion of LPS are shown. Unmodified lipid A consists of a β-1′,6-linked disaccharide of glucosamine that is both phosphorylated and fatty acylated
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Regulation of lipid A remodelling
Lipid A modifications are often necessary only for a portion of the bacterial life cycle, such as host colonization, and as a consequence the enzymes responsible for the modifications are subjected to both transcriptional and post-translational regulation. Many modification enzymes are embedded in the outer membrane in close proximity to lipid A, necessitating tight control for selective enzyme activity, whereas other enzymes are constitutively active regardless of their localization. Two-component systems, small RNAs (sRNAs), peptide feedback loops and substrate availability are all involved in directing the activity of these enzymes (FIG. 2) .
Transcriptional control. Two-component systems are typically composed of a sensor kinase and a response regulator; the sensor kinase is autophosphorylated on stimulation and transfers its phosphate group to the response regulator, which then serves as a transcription factor. To date, various two-component systems have been implicated in the regulation of lipid A modification enzymes, including the widespread PhoPQ and PmrAB (also known as BasRS) systems, and the ParRS and CprRS systems in Pseudomonas aeruginosa [8] [9] [10] [11] [12] [13] . Other systems, such as EvgAS, RcsBC and BvgAS, have been linked to the activity of the PhoPQ system or to downstream PhoPQ-regulated genes, but their direct involvement in the modification of lipid A has not yet been thoroughly investigated [14] [15] [16] [17] . The PhoPQ and PmrAB systems have been reviewed extensively elsewhere 10, 11 , so a brief overview is provided here with a focus on the more recent discoveries.
Functional PhoPQ systems are widespread among bacteria, although there is some interspecies variation in the activation signal used and the genes that are regulated 10, 18 . Activation of the PhoPQ system in Salmonella enterica subsp. enterica serovar Typhimurium by acidic pH, certain antimicrobial peptides, and the depletion of Mg 2+ and Ca 2+ stimulates transcription of pagP and pagL and subsequent upregulation of the encoded proteins, which acylate and deacylate lipid A, respectively 9, 10, [19] [20] [21] (FIGS 1d,2; TABLE 1). Furthermore, both of these enzymes are subjected to post-translational regulation (see below). Because the active sites of these two enzymes are found on the extracellular surface of the outer membrane and in close proximity to lipid A, they require tight control to ensure that lipid A modification is appropriately regulated.
In S. Typhimurium, PhoPQ further influences lipid A modification by activating the PmrAB system, although in E. coli and P. aeruginosa the two systems are not coupled 22 . Direct activation of PmrAB in S. Typhimurium occurs upon sensing Fe 3+ , Al 3+ and low pH, and leads to the upregulation of genes such as arnT (also known as pmrK) and eptA (also known as lptA and pmrC), which transfer 4-amino-4-deoxy-l-arabinose (aminoarabinose) and phosphoethanolamine groups to lipid A, respectively 11 (FIGS. 1d,2a). Similarly to the S. Typhimurium PmrAB system, the P. aeruginosa PmrAB system is activated by the depletion of cations (such as Mg 2+ ), but it is also activated by antimicrobial peptides 23 . In E. coli, S. Typhimurium, P. aeruginosa and other bacteria, the activity of the enzymes controlled by PhoPQ and PmrAB strengthen the integrity of the outermembrane permea bility barrier in the presence of antimicrobial peptides and depleted cations, thus enhancing bacterial survival in the host 24, 25 . The ParRS and CprRS are independent two-component systems that have been found only in P. aeruginosa and respond to subinhibitory concentrations of antimicrobial peptides 12, 13 . Thus, these systems might have an important role during infection. Although both systems upregulate pmrA, pmrB and the genes responsible for the addition of aminoarabinose to lipid A 12, 13 , these systems are differentially activated in response to certain antimicrobial peptides. For instance, the synthetic peptide CP28 activates the CprRS system, whereas the ParRS system seems to be more responsive to the peptide indoli cidin 13 . The two systems react similarly to other peptides, such as polymyxin B and colistin, both of which are used to treat P. aeruginosa infections 13 . P. aeruginosa is a useful, but complex, model pathogen for studying the regulation of lipid A modification because structurally divergent forms of lipid A are associated with different types of infection, including lung infections that result in acute bronchiectasis, and chronic colonization of the cystic fibrosis lung 26 .
Box 1 | Non-lipid A modifications to lipopolysaccharide
Although most lipopolysaccharide (LPS) modifications that are known to affect pathogenesis occur on the lipid A portion of the molecule, the remaining sugars of the LPS molecule can also be modified. Extending from lipid A is the core oligosaccharide, which is subdivided into an inner and an outer core; the O antigen is attached to the outer core (FIG. 1b) . Biosynthesis of these LPS domains varies more across Gram-negative organisms than biosynthesis of lipid A, but within a genus, some components are relatively well conserved. The inner core typically consists of Kdo (3-deoxy-d-mannooctulosonic acid) and heptose sugars, whereas the outer core varies in sugar composition, sugar arrangement and linkage to O antigen. O antigen, in addition to a tremendous variety in composition, can have strikingly different lengths, ranging from the complete absence of O antigen to more than 100 repeating units of sugar backbones with branching chains 1, 109 . These different variants of LPS, particularly the truncation of O antigen, affect the ability of the bacterium to withstand harsh environments 1, 109, 110 .
Various constituents, such as additional sugars, phosphate groups, phosphoethanolamine groups and phosphorylcholine groups, can modify the LPS core regions. Similarly, known O antigen modifications include glycosylation 111 , acetylation 112 , addition of phosphoryl constituents 1 and ligation of acidic repeats such as colanic 113 and sialic 114 acids. In the context of cationic antimicrobial peptide (CAMP) resistance and Toll-like receptor 4 (TLR4) evasion, modifications to the LPS core seem to have more modest roles in pathogenesis than do variations in O antigen length and lipid A modifications, although core modifications can enhance resistance to some CAMPs and to components of the innate immune system, such as complement. A good example of how non-lipid A modifications can affect pathogenesis can be seen in Neisseria gonorrhoeae. This bacterium protects itself from the complement system in human serum by modifying lipooligosaccharide (LOS; LPS in which O antigen is absent and the core region is extended) through the addition of sialic acid and glucose, thus increasing the affinity of LOS for the complement-inhibitory proteins factor H and complement component 4b (C4b)-binding protein, respectively 114, 115 . Furthermore, N. gonorrhoeae producing LOS with a terminal sugar of galactose has an increased association with dendritic cells compared to N. gonorrhoeae that produces LOS containing terminal N-acetylglucosamine. This association with dendritic cells leads to altered cytokine production and T cell responses that could decrease immune responses against the bacterium 116 . Nature Reviews | Microbiology 
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The PhoPQ system has also been shown to mediate modification of lipid A through transcriptional activation of non-coding sRNAs. Many sRNAs modulate the expression of outer-membrane proteins [27] [28] [29] , but recently the sRNA MgrR of E. coli was shown to regulate lipid A modification 30 (FIG. 2a) . MgrR is a transcriptional target of PhoP and is conserved in E. coli and certain Citrobacter, Enterobacter and Klebsiella spp. 30 . This sRNA regulates various genes, including the negative regulation of eptB 30 , which encodes an enzyme that transfers phospho ethanolamine to the outer Kdo (3-deoxy-d-manno-octulosonic acid) residue of LPS 7 (FIG. 1c) . Although EptB activity results in a modest increase in resistance to the cationic antimicrobial peptide (CAMP) polymyxin B, it is unlikely that this is the main function of this enzyme because conditions that inhibit EptB (through activation of the PhoPQ system) simultaneously induce the other PhoPQ-regulated genes, which confer higher CAMP resistance 30 . In addition to regulating an sRNA, the PhoPQ system itself is controlled by another sRNA, MicA (FIG. 2a) , which inhibits translation of PhoP by competitive binding to the ribosome-binding site of the phoP mRNA 31 . MicF represents another example of an sRNA that interacts with lipid A modification enzymes. This sRNA binds to lpxR transcripts, which encode a lipid A deacylase (FIG. 1c; TABLE 1) , and increases degradation of the mRNA by exposing regions that are susceptible to RNase E, a major contributor to RNA turnover in many bacteria 32 .
Post-translational control. In addition to transcriptional regulation, lipid A modification enzymes are subjected to post-translational control mechanisms. For example, in S. Typhimurium, the PmrAB system orchestrates a delayed negative feedback loop that can be activated by Fe 3+ and allows initial uptake of the ion but sets in , which leads to the loss of regulation by the PhoPQ system. The sRNA MicF increases degradation of the lpxR mRNA, which encodes a lipid A deacylase. b | Post-translational control of lipid A modification systems includes inhibition of the kinase LpxT (which phosphorylates lipid A during transport to the outer membrane) by the small peptide PmrR, which is upregulated by the PmrAB system in response to high levels of Fe 3+ (REF. 33 ). Post-translational regulation is also mediated by substrate availability. Membrane perturbation can lead to the displacement of phospholipids from the inner leaflet to the outer leaflet of the outer membrane, placing these donor substrates in close proximity to the acyltransferase PagP, and thus enhancing enzyme activity. PagP cleaves the phospholipid substrate, restoring the composition of the outer membrane and increasing the integrity of the permeability barrier by further acylating lipid A 39 . LpxR deacylates lipid A, but this activity is inhibited by the aminoarabinose lipid A modification.
Complement
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The tagging of pathogens by molecules such as antibodies. These molecules target the foreign entity for destruction by immune system clearance mechanisms such as phagocytosis and the complement system. motion a shift in the cell surface charge that reduces Fe 3+ retrieval from the extracellular environment. This feedback loop is established through PmrAB-induced expression of a short peptide, PmrR, which binds to and inhibits the lipid A-modifying enzyme LpxT This mechanism regulates lipid A-modifying enzymes such as LpxT and those encoded by genes that are transcriptionally induced by PmrAB (such as EptA and ArnT). It also prevents the intracellular accumulation of toxic Fe 3+ and dampens PmrA-dependent transcription in a delayed manner as a result of the lowered affinity of PmrAB-activating Fe 3+ for the membrane. Such small peptide-mediated feedback control of the systems that regulate lipid A modification might be a common theme. In fact, other small peptides, such as SafA (in E. coli) and MgrB (in E. coli, S. Typhimurium and Yersinia pestis), are inner-membrane peptides that interact with the periplasmic domain of PhoQ and activate or repress PhoQ activity, respectively 35, 36 . Other post-translational control mechanisms rely on substrate availability. Although the acyltransferase PagP is transcriptionally upregulated by PhoPQ in organisms such as Salmonella spp. and E. coli, its activation is enhanced by environmental stress and intracellular membrane stress 37 . For example, in E. coli, PagP remains dormant in the outer membrane under standard growth conditions. However, treatment with membrane-perturbing agents, such as EDTA, results in displacement of the phospholipid donor substrate of PagP from the inner to the outer leaflet of the outer membrane, placing it in close proximity to the PagP catalytic domain 38 . PagP cleaves the phospholipid substrate, restoring the composition of the outer membrane and increasing the integrity of the permeability barrier by further acylating lipid A 39 (FIG. 2b) .
The affinity and activity of lipid A modification enzymes are also modulated by the chemical composition of lipid A. For example, in Yersinia enterocolitica, LpxR deacylates lipid A at 37 °C, but at 21 °C LpxR activity is impeded. At 21 °C, pmrAB and the genes necessary for aminoarabinose addition are induced, and the elevated amounts of aminoarabinose residues on lipid A seem to suppress LpxR activity 40 . In S. Typhimurium, PagL is similarly repressed by aminoarabinose modified lipid A, although this effect seems to be temperature independent 21 . These various forms of post-translational regulation afford quick response times for modification of the outer defence barrier, as the enzymes are already present and primed to function as soon as the appropriate signal is detected. Both transcriptional and post-translational regulation work together, sometimes as functionally redundant mechanisms, allowing Gram-negative bacteria to adapt to diverse environments and thereby ensure their survival. The diversity of regulatory mechanisms also illustrates the importance of the lipid A structure to the membrane barrier.
Host defences that target lipid A
Considering the intimate contact that humans have with bacteria, the frequency of colonization with pathogenic Gram-negative bacteria is astonishingly low. This is largely attributed to the formidable arsenal of host defences that eliminate invading pathogens by recognizing and responding to highly conserved components of infectious agents, known as MAMPs 41 . Because LPS is an essential component of the Gram-negative cell surface, it serves as an effective MAMP to trigger the innate immune system 1 . The host offers a nutrient-rich but perilous environment for a bacterium. For example, intestinal colonization requires a bacterium to journey through the acidic pH of the stomach and encounter toxic compounds such as bile and antimicrobials during transit 42 , and the bloodstream is swarming with LPSbinding proteins, antibodies, complement and immune cells primed to detect LPS 1, [43] [44] [45] [46] . Every point of entry for a bacterium is well defended, but as many of the protective mechanisms rely on lipid A detection, the modification of lipid A affords the bacterium an opportunity to evade the immune system and establish an infection.
Charge-dependent binding of lipid A. Charge-dependent binding of various host molecules (such as CAMPs, platelet factor 4 (PF4) and members of the complement system) to the bacterial cell surface is a major contributor to host protection. CAMPs are amphipathic molecules that are present on mammalian mucosal surfaces, in bodily secretions (such as sweat and saliva) and in phagocytic cells. CAMP production is a highly conserved defence mechanism of most organisms, but the peptides vary widely in terms of their composition and structure. The genes encoding CAMPs are among the most rapidly evolving mammalian genes 47 , and it has been hypothesized that this represents an example of co-evolution, wherein the genes are under selective pressure to mutate as a consequence of the evolution of bacterial resistance to the encoded proteins 48 . One of the primary mechanisms proposed for CAMP-mediated bactericidal activity is association of the positively charged peptides with negatively charged lipid A, followed by CAMP insertion into the bacterial membrane and disruption of the membrane potential, leading to cell death 42, 48 . PF4 is another positively charged host molecule that is conserved across vertebrates and is released following platelet activation during infection. This molecule binds the bacterial cell surface at the lipid A domain. Antibodies specific for PF4-lipid A complexes are subsequently produced, leading to increased opsonization and phagocytosis of the bacterium 43 . Furthermore, complement proteins also bind lipid A and modulate the activation of the classical complement pathway to promote bacterial clearance [44] [45] [46] .
Toll-like receptor 4 signalling. Lipid A is recognized by the Toll-like receptor 4 (TLR4)-MD2 (also known as 
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LY96) receptor, one of many pattern recognition receptors (PRRs) of the mammalian innate immune system. This receptor is present on a wide variety of cell types, including monocytes, lymphocytes and endothelial cells 1 . Binding of TLR4-MD2 to lipid A triggers a signalling cascade that leads to inflammation, cytokine production and the eventual clearance of bacteria through recruitment of effector cells, phagocytosis, cytotoxicity and activation of the complement system 49 (FIG. 3) . This inflammatory response can be severe, resulting in tissue damage, organ failure and death, especially in cases of sepsis 1 . Unmodified E. coli lipid A, which contains six acyl chains and two phosphate groups, is the strongest known TLR4 ligand, and lipid A modifications can weaken or abolish TLR4 signalling and change the nature of the downstream cytokine profile (see below) [50] [51] [52] [53] . The detection of lipid A by TLR4 begins with LPSbinding protein (LBP) and CD14 binding to LPS and the subsequent transfer of LPS to the TLR4-MD2 complex. This complex can then signal through two major pathways, which are named according to their adaptor proteins: myeloid differentiation primary response protein 88 (MYD88) and TIR domain-containing adaptor inducing IFNβ (TRIF; also known as TICAM1) 54 (FIG. 3) . Severe reactions to LPS are attributed to activation of the MYD88 pathway, which induces the production of pro-inflammatory cytokines such as tumour necrosis factor (TNF), interleukin-6 (IL-6) and IL-12. The less inflammatory TRIF (or MYD88-independent) pathway occurs after endocytosis of the TLR4-MD2 receptor and is characterized by the production of interferon-β (IFNβ) and IFN-inducible proteins such as 10 kDa IFNγ-induced protein (IP10; also known as CXCL10), monocyte chemoattractant protein 1 (MCP1; also known as CCL2), RANTES (also known as CCL5) and granulocyte colony-stimulating factor (G-CSF) 55 . Although it is important for mounting an optimal immune response to pathogens, the TRIF pathway does not lead to severe inflammation. Unmodified LPS from E. coli induces signalling through both pathways, but lipid A modifications can cause preferential recruitment of one adaptor protein over the other 56 
. In vivo, bacterial lipid A modifications are also known to affect the potency of TLR4 activation, as described below 7 .
Bacterial evasion strategies
Modification of lipid A equips Gram-negative bacteria with an ability to evade immune recognition and survive within a host. First, by changing the overall charge of the bacterial surface through the addition of chemical groups to lipid A, such as the addition of phosphoethanolamine and aminoarabinose, resistance to innate immune effectors (for example, CAMPS and complement factors) increases. Second, changes in the structure of lipid A are important for bacterial pathogenesis because they directly affect recognition by the TLR4-MD2 receptor, and the degree of lipid A acylation and phosphorylation is crucial for LPS recognition by TLR4-MD2 57 . Finally, certain modifications (such as those regulated by PhoPQ) alter the properties of the outer-membrane permeability barrier, which provides resistance to harsh pH and antibiotics, among other stresses.
There are benefits and costs associated with each modification: as bacteria adapt to protect themselves against certain assaults, this might result in the loss of protection against others. For instance, PhoPQ-and PmrAB-induced lipid A modifications increase resistance to CAMPS, but constitutive activation of PmrAB has been shown to reduce the resistance of E. coli to the bile component deoxycholate 58 (FIG. 1d) . The bacterium has a diverse lifestyle and fine-tunes the composition of lipid A in response to the surrounding environment 7, 59 . During infection, S. Typhimurium penetrates the epithelial lining of the small intestine, invades lymphoid tissue and infects host phagocytes 60 . The unmodified lipid A synthesized by this organism is identical to that produced by E. coli K12 (FIG. 1c) . However, survival is promoted in the intestinal lumen and within host cells (where the bacterium encounters CAMPs, low pH and possibly other unknown signals) by activation of the PhoPQ and PmrAB systems, leading to the addition of phosphoethanolamine and aminoarabinose by EptA and ArnT, respectively, and to acyl chain remodelling by PagP and PagL 19 (FIG. 1d) . Commensal and pathogenic E. coli strains also encode these lipid A modification enzymes, but little is known about their regulation in vivo. In S. Typhimurium, another enzyme, LpxO, hydroxylates lipid A (FIG. 1d) as part of a coordinated stress response 61 . The combination of these modifications results in a remodelled outer membrane with a reduced net negative charge and increased integrity, which enhances virulence 9, 25 . Helicobacter pylori. The human stomach is the sole niche of H. pylori, and the organism is so well adapted to this environment that it colonizes roughly 50% of the world's population and can persist for decades within a single host 62 . To survive chronically in the host and remain undetected, H. pylori uses two constitutive lipid A-mediated evasion strategies: repulsion of CAMPs (which are present at high concentrations in the gastric mucosa) and evasion of detection by TLR4 (FIG. 4a) . Similarly to most Gram-negative bacteria, H. pylori synthesizes a hexa-acylated lipid A, but displays a tetra-acylated molecule lacking phosphate groups on the bacterial surface. This striking structural difference between the originally synthesized lipid A and the surface-exposed molecule is due to the actions of several enzymes, including dephosphorylation by LpxE and LpxF, addition of phosphoethanolamine by EptA and deacylation by LpxR (TABLE 1) . These modifications confer resistance to polymyxin B as well as other biologically relevant CAMPs 63 . The reduced acylation . The MYD88-dependent pathway leads to the production of pro-inflammatory cytokines, whereas the less inflammatory TRIF pathway occurs after endocytosis of the TLR4-MD2 receptor and stimulates the expression of interferon (IFN)-inducible genes that are important for adjuvanticity but are less inflammatory than those cytokines induced by the MYDD88-dependent pathway. 
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and phosphorylation of lipid A also lead to decreased stimulation of TLR4 and the downstream signalling cascade 50, 64, 65 . When these modification systems are inactivated through mutation, H. pylori displays hexa-acylated, bis-phosphorylated lipid A (FIG. 4a) , which is a strong stimulator of TLR4 (REF. 63 ). The constitutive lipid A modifications to the acyl chains and phosphate groups are adaptations that allow this bacterium to persist in the harsh gastric environment amidst the several antibacterial components of the innate immune response.
Yersinia pestis and Francisella tularensis. Y. pestis is notorious for its role in human disease throughout history, causing the Black Death plague that killed approximately one-third of the European population in the fourteenth century 66 . The bacterium has a complex life cycle, colonizing both the flea and human host 67 . This transition between hosts coincides with a switch in the composition of lipid A 68 (FIG. 4b) . Inside the flea, Y. pes tis grows at a temperature of between 21 °C and 27 °C and synthesizes a hexa-acylated lipid A similar to the highly inflammatory E. coli lipid A that strongly stimulates TLR4 (REF. 69 ). In humans, Y. pestis encounters a temperature of 37 °C and replaces the agonist form of lipid A with a tetra-acylated form that is a TLR4 antagonist. The tetra-acylated form of lipid A is believed to allow the pathogen to proliferate undetected in the bloodstream during the early stages of infection 70, 71 . Heterologous expression of the E. coli acyltransferase LpxL in Y. pestis restores hexa-acylated lipid A and strong TLR4-stimulatory properties 70 . Strains that can produce only hexa-acylated lipid A are also avirulent in mice, suggesting that deacylation of lipid A is required for TLR4 evasion and is crucial for Y. pestis pathogenesis 70 . Similarly to Y. pestis, the lipid A of F. tularensis is modified according to temperature, affecting membrane integrity and pathogenesis in the environmental vectors of this pathogen, such as protozoa and arthropods (18-26 °C) , and mammalian hosts (37 °C) . This bacterium has two homologues of LpxD, an essential lipid A biosynthesis acyl transferase that incorporates longer acyl chains at high temperature (37 °C) than at lower temperatures (25 °C and 18 °C) 72 . A mutant strain that is unable to produce lipid A with longer acyl chains is avirulent in mice and is also more susceptible to antibiotics and CAMPs owing to increased membrane permeability 72 . These two examples of lipid A modifications emphasize the fact that appropriate adaptation in response to temperature is important for altering the fluidity of the outer membrane, and that this alteration is needed to maximize Y. pestis and F. tularensis virulence.
Vibrio cholerae. V. cholerae, the causative agent of the severe diarrhoeal disease cholera, commonly survives on marine crustaceans such as copepods and can be acquired by humans through ingestion of copepods, leading to intestinal disease 73 . The V. cholerae O1 El Tor biotype is currently causing a seventh worldwide pandemic affecting an estimated 3-5 million people, but the previous six pandemics were caused by the classical biotype V. cholerae O1. These two biotypes can be differentiated by their sensitivity to polymyxin B 74 , as V. cholerae O1 El Tor is 100-fold more resistant to polymyxin B than the classical V. cholerae O1 strains. This resistance is conferred by an unusual lipid A modification. A threegene operon in V. cholerae (almEFG) encodes enzymes that transfer a glycine or diglycine residue to a 3′-linked acyl chain of lipid A 75 (FIG. 4c) . This is the first described amino acid modification of lipid A, and it has revealed a unique link between Gram-negative and Gram-positive cell wall decoration 75, 76 , as Gram-positive bacteria can transfer the amino acid alanine to wall teichoic acids and wall lipoteichoic acids and thus reduce the net negative charge of the cell wall 76 . The amino acid modification of lipid A in V. cholerae has little effect on TLR4 activation, suggesting that it has evolved for the distinct purpose of promoting survival in the presence of CAMPs in the marine and human host environment 75 .
Box 2 | Lipid A as a tool for immune system modulation
By chemically or biologically modifying the phosphate groups and acyl chains of lipid A, the therapeutic potential of this lipopolysaccharide (LPS) component can be harnessed while limiting the inflammatory effects of the molecule 50, 54, 64 . In fact, a chemically detoxified mixture of monophosphorylated lipid A species (MPL) derived from Salmonella enterica subsp. enterica serovar Minnesota (the predominant species of which is 3-O-deacyl-4′-monophosphoryl lipid A; see the figure) recently became the first US Food and Drug Agency (FDA)-approved vaccine adjuvant in more than 70 years, bringing the number of FDA-approved Toll-like receptor (TLR) agonists up to three 54, 117 . We predict that TLR ligands are likely to be the future of vaccines and could benefit other areas as well, such as cancer research, gene therapy and bacterial production of pharmaceuticals.
Lipid A derivatives like MPL have been well studied for their agonistic properties in terms of immune stimulation 54 . However, MPL is the only lipid A that has been tested in human cancer vaccine trials 118 , and almost all studies have focused on cervical cancer, as MPL is used as the vaccine adjuvant against the oncogenic human papilloma virus (HPV) 117 . Considering the evidence that TLR4 signalling can be biased to produce certain types of cytokine responses 56 , further study of other modified lipid A structures, as well as chemically synthesized lipid A variants 119 , could prove advantageous for the development of vaccine adjuvants. To facilitate such work, an Escherichia coli library was recently engineered to synthesize lipid A variants with a spectrum of endotoxicity 120 . These lipid A variants have the potential to be used as components of whole cells, LPS or purified lipid A and might be used as vaccine adjuvants in the future.
Whole-cell vaccine strains of some organisms, such as Salmonella enterica subsp. enterica serovar Typhimurium, have been engineered to synthesize altered lipid A structures in order to reduce the toxicity of the vaccine. Heterologous expression of an antigen from Streptococcus pneumoniae in such strains provides protection against both S. Typhimurium and S. pneumoniae 51, 52 . Similarly, outer-membrane vesicles from Neisseria meningitidis producing modified lipid A are now prime candidates for vaccination against N. meningitidis Host modification of lipid A Host tolerance of commensal bacteria. The host environment at mucosal surfaces is rich in LPS, as this compound is produced in abundance by commensal Gram-negative bacteria. This means that the immune response at these surfaces needs to be modulated to promote tolerance to commensals but to mount a defence against pathogens. In general, enteric bacteria produce highly stimulatory, hexa-acylated lipid A 77 , although decorating the cell surface with such an efficient immunostimulant seems counterintuitive as a strategy for commensal bacteria. In the gastrointestinal
Wall teichoic acids
Long anionic glycopolymers that are covalently linked to the peptidoglycan of Gram-positive bacteria and extend beyond the cell wall.
Wall lipoteichoic acids
Teichoic acids that are anchored to the plasma membrane of Gram-positive bacteria and extend into the peptidoglycan layer.
Chylomicrons
Small micelles that are composed of lipids, lipoproteins and proteins, and function to transport lipids.
lumen, tolerance of commensals is partly attributed to the limited expression of TLR4 on the apical surface of epithelial cells, which means that TLR4 expression in the subepithelial layers is important to restrict infection following damage to the outer layer of cells. On the other hand, Paneth cells in the small intestine have recently been shown to produce multiple antimicrobial proteins in order to control inflammation and infection caused by Gram-negative bacteria, and this response is triggered directly in a TLR4-dependent manner by the presence of bacteria and purified LPS 78 . Paneth cells seem perfectly situated to respond appropriately to commensal bacteria, producing an antimicrobial moat that keeps bacterial numbers balanced to avoid excessive inflammation but permit enough commensal colonization to impede invasion by pathogens 78 .
Host detoxification of lipid A. When the innate immune response has been triggered by Gram-negative bacteria that have successfully breached the mucosal and epithelial barriers, LPS must be inactivated or removed from the bloodstream to reset the immune response for subsequent LPS exposure. Various host response mechanisms are involved in clearance of and tolerance to LPS from commensal and pathogenic bacteria. Covalent modification of lipid A by host enzymes is one mechanism to inactivate lipid A. The mammalian lipase acyloxyacyl hydrolase (AOAH) is produced by macrophages, dendritic cells and neutrophils and cleaves all secondary linked acyl chains of lipid A (that is, the O-linked acyl chains that are attached to one of the four primary acyl chains linked directly to the sugar backbone) 79 . This renders the LPS molecule less inflammatory owing to impaired interactions with TLR4 (REFS 50, 64) . Exposure of AOAH-deficient mice to LPS results in prolonged tolerance or unresponsiveness to LPS; this effect can last for months, thus limiting the capacity of the host to react to a secondary exposure. By contrast, wild-type mice are able to recover and respond normally to LPS within 5-10 days 80 . AOAH activity increases during LPS challenge in rabbits and mice, suggesting that this enzyme has a primary role in LPS detoxification 79, 80 . Host alkaline phosphatases have also been shown to modify LPS through the removal of phosphate groups. Whether these phosphatases act on both lipid A and the sugar chains of LPS requires further study, although several studies have shown that alkaline phosphatases interact with LPS in vivo [81] [82] [83] . Similarly to deacylation, removal of the lipid A phosphate groups results in reduced TLR4 stimulation and reduced LPS potency 50 . Recently, a direct link between LPS and one of these phosphatases (intestinal alkaline phosphatase (Iap; also known as Alpi1)) was identified in zebrafish. This particular phosphatase probably cleaves phosphate groups from the lipid A domain of LPS, and it controls the inflammatory response to gut microorganisms. Zebrafish with mutations in iap are sensitive to LPS, whereas in wild-type zebrafish, LPS induces TLR4-dependent signalling that upregulates the transcription of iap, effectively lowering LPS toxicity 83 .
Lipopolysaccharide scavenging. Many other host molecules have been identified that associate with LPS (usually at the lipid A domain) and assist in reducing endotoxin concentration in the body and trafficking LPS for disposal. These molecules have been shown to reduce LPS toxicity by direct binding to LPS or by competing with it for association with essential cofactors of TLR4 (CD14 and LBP) 84 . For example, pre-incubation of the antimicrobial peptide LL-37 with LPS results in reduced cytokine induction in exposed THP-1 cells compared with exposure to LPS alone, suggesting that LL-37 is an LPS scavenger 85 . The abundant plasma protein β 2 glycoprotein I (β 2 GPI) forms complexes with LPS through an LPS-binding domain that is well conserved across vertebrates 86 . Binding of β 2 GPI to LPS causes a conformational change in β 2 GPI that leads to the association of these complexes with monocytes and subsequent clearance of LPS 87 . LBP is important for binding LPS and recruiting it to CD14 and TLR4 to induce immune signalling, but it has also been implicated in a mechanism of neutralizing LPS by transferring the endotoxin to high-and low-density lipoprotein and to chylomicrons, enhancing clearance of LPS following uptake by the liver 88, 89 . The direct binding of host factors to lipid A, as well as the effects of lipid A modifications on the above mechanisms, have not yet been investigated, but further studies could reveal additional evasion strategies that are used by Gram-negative bacteria to promote pathogenesis.
Effects on other cellular processes Recent studies have revealed links between lipid A modifications and diverse processes within the bacterial cell. These associations support the notion that lipid A modifications are crucial for bacterial pathogenesis and survival. pylori, and the bacterium has adapted to this environment by constitutively modifying lipid A to a form that resists cationic antimicrobial peptides (CAMPs) and evades the lipid A receptor, Toll-like receptor 4 (TLR4). Surface expressed H. pylori lipid A consists of a tetra-acylated form that lacks the 4ʹ-phosphate group and is substituted at the C1 position with a phospho ethanolamine 63 . Lipid A modification mutants present a hexa-acylated, bis-phosphorylated species that is a TLR4 agonist. b |When residing in the flea vector, Y. pestis produces an endotoxic hexa-acylated lipid A that is a strong immunostimulant in humans. Following transmission to the human host, the bacterium senses a shift in temperature (from 21-27 °C to 37 °C) and synthesizes tetra-acylated lipid A, which escapes detection by TLR4, and immune stimulation is thereby curtailed 70 . c | V. cholerae normally inhabits freshwater, estuarine and oceanic environments and often colonizes marine organisms such as copepods, which are important for cholera transmission. Copepod colonization provides an environment that probably induces lipid A modifications which are crucial for marine and host survival, a prospect that is currently under investigation. The V. cholerae O1 El Tor biotype modifies lipid A with a glycine or diglycine residue, providing resistance to CAMPs, whereas the classical V. cholerae O1 biotype remains susceptible 75 .
◀
Flagellar rod
The central, structural component of bacterial flagella that spans the periplasm.
Flagella
Whip-or tail-like appendages that are synthesized by many bacteria and are important for motility.
Outer-membrane vesicles
Small, spherical outermembrane blebs that are released from Gram-negative bacterial cells and contain membrane and periplasmic components.
Multitarget lipid A modification enzymes. In Campylo bacter jejuni, the enzyme EptC modifies both lipid A and a structural protein required for the assembly of flagella. EptC is a homologue of E. coli EptA, and both enzymes transfer a phosphoethanolamine residue to the 1′ and 4′ positions of lipid A (TABLE 1) , masking both phosphate groups and promoting CAMP resistance. Interestingly, in C. jejuni, EptC also transfers an essential phosphoethanolamine to FlgG (a flagellar rod protein 90 ), and EptC mutants lack wild-type motility and produce fewer flagella, which are required for virulence. This promiscuous C. jejuni enzyme also modifies carbohydrates of the LOS core and glycosylated proteins 91 .
Recycling of biosynthetic intermediates. During the assembly of bacterial polymers (for example, peptido glycan, the capsule and LPS), a wide array of glyco conjugates must be trafficked across the inner membrane 92 . These glycan intermediates are assembled on a universal carrier lipid known as undecaprenyl phosphate (C 55 -P) 93 . The C 55 -P transports the glycan precursors via a pyrophosphate linkage (C 55 -PP-precursor), and when the precursor is removed, the carrier lipid is released as a pyrophosphate and requires dephosphorylation in order to be recycled 93 .
Within the periplasm, LpxT transfers a secondary phosphate group onto lipid A at the 1 position (FIG. 1c) and uses C 55 -PP as a donor 94 . This finding represented a novel and unexpected link between the modification of lipid A and the recycling of C 55 -PP. Furthermore, the connection between these systems implies that C 55 -PP could serve as a high-energy phosphate donor for various periplasmic components, although these potential targets are largely unidentified.
Activation of outer-membrane proteins. As a membrane component, LPS is more than just a platform for activities at the cell surface 95 . It also has a role in the activation of omptins, a class of proteases that is widespread among Gram-negative enteric bacteria. The activity of one member of this class, OmpT, has been evaluated in the presence of hexa-acylated and tri-acylated lipid A forms, and the protease was found to be active only in the presence of hexa-acylated lipid A 96 . Interestingly, another omptin named plasminogen activator (Pla), which is central to Y. pestis pathogenesis, is more active in Y. pestis grown at 37 °C and producing tetra-acylated lipid A than in cells grown at 20 °C and producing hexa-acylated lipid A
.
Outer-membrane vesicles and toxin delivery. Lipid A modifications also affect the delivery of proteins and toxins that are associated with the outer membrane and outer-membrane vesicles (OMVs). In organisms such as Porphyromonas gingivalis and P. aeruginosa, negatively charged LPS is enriched in OMVs 98, 99 . Furthermore, in P. gingivalis, the lipid A found in OMVs is more deacylated than that present in whole-cell membranes, suggesting that lipid A modification facilitates vesicle formation or the sorting of outer-membrane proteins that are packaged into vesicles 98 . In P. aeruginosa, OMV formation is stimulated by a small signalling molecule called Pseudomonas quinolone signal (PQS), which is packaged into vesicles and induces vesicle formation in P. aeruginosa as well as other bacteria 100 . The exact mechanism of OMV formation is not understood; however, PQS was found to interact with the 4′-phosphate group and acyl chains of lipid A, indicating that modification of lipid A could influence the efficiency of vesicle shedding 101 . The structure of lipid A and the Kdo residues of LPS also affect the delivery of toxins. For example, two similar toxins -cholera toxin (CT), produced by V. cholerae, and heat-labile enterotoxin (LT), produced by enterotoxigenic E. coli (ETEC) -are both secreted, are structurally similar and bind the same host cell receptor. However, CT causes a more severe diarrhoeal disease than LT 102 . Although the topic is controversial 103 , the difference in toxin severity seems to be due to the partial sequestration of LT, as it binds to Kdo-lipid A on the bacterial cell surface after secretion. By contrast, the Kdo sugar attached to lipid A in V. cholerae is phosphorylated by Kdo kinase (KdkA) (TABLE 1) , and this modification inhibits CT association with the outer membrane, thereby allowing robust toxin secretion 104 .
Conclusions and future prospects
The wide variety of lipid A modifications equips Gramnegative bacteria for survival in their respective niches in the host and other environments. Other functions of lipid A are highlighted by the interplay of lipid A modifications with a diverse set of cellular processes, and both of these facets of lipid A biology emphasize the importance of a continued effort to understand the regulation, benefits and host response to lipid A in its numerous modified forms.
However, many questions remain unanswered. The continued development of animal models is paramount to more closely mimic the host infection site. Considerable progress has been made in this regard by the recent generation of a transgenic mouse expressing the human TLR4 receptor 105 . Furthermore, there is much to learn about how lipid A and its modifications affect the outcome of polymicrobial infections, with recent studies suggesting that LPS has an important role within such communities. For instance, purified LPS from intestinal commensal bacteria has been found to promote replication and transmission of viruses 106, 107 . Pathogenesis of orally acquired poliovirus, which replicates in the intestine before spreading to cause a severe systemic infection, is supported by the intestinal microbiota and purified LPS 107 . Mouse mammary tumour virus (MMTV) manipulates the innate immune response by binding LPS and eliciting TLR4-dependent production of IL-10, a cytokine that is required for MMTV persistence 106 . Although these viruses bind LPS and this enhances infectivity in vitro, how lipid A modifications affect these phenomena is currently unknown.
Improved methods for studying lipid A modifications in vivo could also help elucidate any potential links between modified lipid A and diseases involving TLR4, such as inflammatory bowel disease, diabetes, rheumatoid arthritis and atherosclerosis 108 . Important insights into human TLR4 polymorphisms might now be possible using the humanized mouse model 105 , and it should also be possible to examine how different variants of TLR4 affect susceptibility to infection by organisms with modified lipid A. This could potentially lead to more personalized medical treatment through the development of a new range of modified TLR4 agonists that could serve as customized immunomodulatory agents to induce or repress particular cytokine responses.
It remains a mystery why lipid A is essential in virtually all Gram-negative organisms. Furthermore, why lipid A biosynthesis is well conserved only to have complex (and varying) modifications occur later, sometimes constitutively, is not understood. How the modification enzymes are distributed and organized within the membrane is also unclear. For example, it is not known whether lipid rafts exist in bacteria and whether some or all of the modification enzymes are enriched at these sites. Lipid A molecules with certain modifications could also be specifically localized in the membrane. Such an organization could have a major influence on the activation of key outer-membrane proteins or on OMV formation and protein sorting.
With further study, inhibitors of modification enzymes could be developed for use as antibiotics or in combination with currently used antibiotics. Although immense progress has been made in our understanding of lipid A modification systems in Gram-negative bacteria and their importance for pathogenesis, there is much work yet to be done.
